Literature DB >> 23912754

Pharmacologically assisted treatment of opioid-dependent youth.

Anna Pecoraro1, Marc Fishman, Michelle Ma, Gvantsa Piralishvili, George E Woody.   

Abstract

Opioid misuse, abuse, and dependence are global problems whose patterns vary across cultures. In the USA, the non-medical use of prescription opioids has become particularly serious because of its association with addiction and overdose death. Agonist and antagonist medications have been shown to be effective for opioid-dependent adults, and there is a growing body of data that they are also effective for youth. Here, we summarize evidence that detoxification alone results in high rates of treatment dropout and relapse but that the limited but growing data on the extended use of medication-assisted treatment for opioid-dependent youth have been positive. The implementation of medication-assisted treatment as a standard practice is feasible, easily integrated with counseling or psychotherapy, and has potential to greatly improve outcomes. Although concerns about safety and efficacy with youth require more research, and we do not advocate indefinite maintenance, we suggest that opioid-dependent youth should be considered as candidates for medication-assisted treatment delivered in a comprehensive, developmentally appropriate context, beginning at the first episode of care, with the strength of the recommendation to use medication increasing with each care episode.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912754     DOI: 10.1007/s40272-013-0041-5

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  33 in total

1.  Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility.

Authors:  Marc J Fishman; Erin L Winstanley; Erin Curran; Shannon Garrett; Geetha Subramaniam
Journal:  Addiction       Date:  2010-07-09       Impact factor: 6.526

2.  Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.

Authors:  Maria A Sullivan; Suzanne K Vosburg; Sandra D Comer
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

3.  One-year mortality rates following methadone treatment discharge.

Authors:  D A Zanis; G E Woody
Journal:  Drug Alcohol Depend       Date:  1998-11-01       Impact factor: 4.492

4.  Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.

Authors:  Evgeny Krupitsky; Edward V Nunes; Walter Ling; Ari Illeperuma; David R Gastfriend; Bernard L Silverman
Journal:  Lancet       Date:  2011-04-30       Impact factor: 79.321

Review 5.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  L Amato; M Davoli; S Minozzi; R Ali; M Ferri
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

7.  Overcoming opioid blockade from depot naltrexone (Prodetoxon).

Authors:  E M Kruptisky; A M Burakov; M V Tsoy; V Y Egorova; T Y Slavina; A Y Grinenko; E E Zvartau; G E Woody
Journal:  Addiction       Date:  2007-07       Impact factor: 6.526

Review 8.  Detoxification treatments for opiate dependent adolescents.

Authors:  Silvia Minozzi; Laura Amato; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.

Authors:  Gary K Hulse; Noella Morris; Diane Arnold-Reed; Robert J Tait
Journal:  Arch Gen Psychiatry       Date:  2009-10
View more
  8 in total

Review 1.  Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.

Authors:  Jacob T Borodovsky; Sharon Levy; Marc Fishman; Lisa A Marsch
Journal:  J Addict Med       Date:  2018 May/Jun       Impact factor: 3.702

2.  Still "at risk": An examination of how street-involved young people understand, experience, and engage with "harm reduction" in Vancouver's inner city.

Authors:  Nikki Bozinoff; Will Small; Cathy Long; Kora DeBeck; Danya Fast
Journal:  Int J Drug Policy       Date:  2017-06-01

3.  Buprenorphine and its formulations: a comprehensive review.

Authors:  Salomon Poliwoda; Nazir Noor; Jack S Jenkins; Cain W Stark; Mattie Steib; Jamal Hasoon; Giustino Varrassi; Ivan Urits; Omar Viswanath; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-08-20

4.  Non-medical prescription opioid use predicts injection initiation among street-involved youth.

Authors:  Kora DeBeck; Evan Wood; Huiru Dong; Sabina Dobrer; Kanna Hayashi; Julio Montaner; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2016-06-01

5.  Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.

Authors:  Derek C Chang; Jan Klimas; Evan Wood; Nadia Fairbairn
Journal:  Am J Drug Alcohol Abuse       Date:  2017-11-30       Impact factor: 3.829

6.  Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.

Authors:  Charles J Neighbors; Sugy Choi; Shannon Healy; Rajeev Yerneni; Tong Sun; Liudmila Shapoval
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-06-25

Review 7.  Comorbid chronic pain and opioid misuse in youth: Knowns, unknowns, and implications for behavioral treatment.

Authors:  Melissa Pielech; Claire E Lunde; Sara J Becker; Kevin E Vowles; Christine B Sieberg
Journal:  Am Psychol       Date:  2020-09

8.  Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting.

Authors:  Kora DeBeck; Thomas Kerr; Seonaid Nolan; Huiru Dong; Julio Montaner; Evan Wood
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.